Erythrocyte Complement Receptor 1 and Alzheimer Disease

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 29, 2012

Study Completion Date

April 30, 2015

Conditions
Alzheimer Disease
Interventions
OTHER

CR1 impact

Trial Locations (1)

51092

CHU de REIMS, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER

NCT01565434 - Erythrocyte Complement Receptor 1 and Alzheimer Disease | Biotech Hunter | Biotech Hunter